
 [
{
"symbol" : "524212",
"exchange" : "BOM",
"id": "715472",
"t" : "524212",
"e" : "BOM",
"name" : "Wanbury Limited"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:524212"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:524212"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:524212"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "",
"annual" : "-1.16%",
"ttm" : ""
},
{
"title" : "Operating margin",
"recent_quarter" : "",
"annual" : "1.96%",
"ttm" : ""
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "4.32%",
"ttm" : ""
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "-1.25%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "",
"ttm" : ""
}
]
, "c" : "+0.45",
"l" : "32.10",
"cp" : "1.42",
"ccol" : "chg",
"op" : "31.50",
"hi" : "32.10",
"lo" : "30.60",
"vo" : "2,287.00",
"avvo" : "",
"hi52" : "59.00",
"lo52" : "30.60",
"mc" : "746.44M",
"pe" : "",
"fwpe" : "",
"beta" : "",
"eps" : "",
"dy" : "",
"ldiv" : "",
"shares" : "23.72M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "715472",
"name" : "Wanbury Limited",
"t" : "524212",
"e" : "BOM",
"l" : "32.10",
"c" : "+0.45",
"mc" : "746.44M",
"cp" : "1.42",
"ccol" : "chg"
}
,
{
"id" : "10147154",
"name" : "Natco Pharma Ltd.",
"t" : "NATCOPHARM",
"e" : "NSE",
"l" : "800.25",
"c" : "-0.10",
"mc" : "148.44B",
"cp" : "-0.01",
"ccol" : "chr"
}
,
{
"id" : "6462769",
"name" : "Torrent Pharmaceuticals Ltd",
"t" : "TORNTPHARM",
"e" : "NSE",
"l" : "1,363.00",
"c" : "+15.50",
"mc" : "229.18B",
"cp" : "1.15",
"ccol" : "chg"
}
,
{
"id" : "719680",
"name" : "Ameya Laboratories Ltd",
"t" : "532981",
"e" : "BOM",
"l" : "0.23",
"c" : "-0.01",
"mc" : "58.78M",
"cp" : "-4.17",
"ccol" : "chr"
}
,
{
"id" : "5394531",
"name" : "Neuland Laboratories Ltd.",
"t" : "NEULANDLAB",
"e" : "NSE",
"l" : "786.50",
"c" : "-14.35",
"mc" : "6.73B",
"cp" : "-1.79",
"ccol" : "chr"
}
,
{
"id" : "6286747",
"name" : "Anuh Pharma Ltd",
"t" : "506260",
"e" : "BOM",
"l" : "163.50",
"c" : "-4.35",
"mc" : "3.78B",
"cp" : "-2.59",
"ccol" : "chr"
}
,
{
"id" : "6809657",
"name" : "Aarti Drugs Ltd.",
"t" : "AARTIDRUGS",
"e" : "NSE",
"l" : "555.90",
"c" : "-17.10",
"mc" : "12.86B",
"cp" : "-2.98",
"ccol" : "chr"
}
,
{
"id" : "3900000",
"name" : "Smruthi Organics Ltd",
"t" : "540686",
"e" : "BOM",
"l" : "102.00",
"c" : "-8.85",
"mc" : "412.79M",
"cp" : "-7.98",
"ccol" : "chr"
}
,
{
"id" : "20411139269060",
"name" : "Medico Remedies Ltd",
"t" : "540937",
"e" : "BOM",
"l" : "97.25",
"c" : "+0.20",
"mc" : "405.58M",
"cp" : "0.21",
"ccol" : "chg"
}
,
{
"id" : "14272879",
"name" : "Granules India Ltd",
"t" : "GRANULES",
"e" : "NSE",
"l" : "93.70",
"c" : "-2.40",
"mc" : "23.43B",
"cp" : "-2.50",
"ccol" : "chr"
}
,
{
"id" : "3033292",
"name" : "Hiran Orgochem Ltd",
"t" : "506170",
"e" : "BOM",
"l" : "0.48",
"c" : "0.00",
"mc" : "47.63M",
"cp" : "0.00",
"ccol" : "chb"
}
]
, "summary" : [{
"address": "\u0027B\u0027 Wing, 10th Floor, BSEL Techpark Opp. Vashi Railway Station, Sector 30A Vashi, NAVI MUMBAI, 400703, India",
"phone": "+91-22-67942222",
"fax": "+91-22-67942111",
"url": "http:\u002F\u002Fwww.wanbury.com\u002F",
"overview" : "Wanbury Limited is a pharmaceutical company. The Company offers active pharmaceutical ingredient (API) in over 70 countries. The Company offers products in the categories, such as anti-diabetic, anti-depressant, anti-histaminic, anti-inflammatory, anti-depressant, anti-arthritis, anti-thrombotic, anti-epileptic and anti-hypertensive. The Company\u0027s API products include metformin, tramadol, sertraline, diphenhydramine citrate, mefenamic acid, paroxetine hemihydrate, promethazine, glucosamine, clopidogrel, levitiracetam and carvedilol phosphate monohydrate, among others. The Company operates through four divisions: Main division, which caters to general doctors\u003B Osteolife, which offers solutions to orthopedic doctors\u003B Surglife, which offers services to surgeons, and WOW, which caters to gynecologists. The Company\u0027s brands include Cpink, Rabiplus, Folinine, Adtrol Plus, CEMAX, AUGCEF, Pantastic, CHEER and Nurture, among others."
} ]
, "management" : [
{
"name" : "K. Chandran",
"age" : "56",
"title" : "Vice Chairman of the Board"
}
,
{
"name" : "Vinod Verma",
"title" : "Chief Financial Officer"
}
,
{
"name" : "Jitendra J. Gandhi",
"title" : "Compliance Officer, Company Secretary"
}
,
{
"name" : "Divakar Kaza",
"title" : "Non-Executive Non-Independent Director"
}
,
{
"name" : "Sudip K. Bhattacharyya",
"age" : "64",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "N. K. Puri",
"age" : "71",
"title" : "Non-Executive Independent Director"
}
]
,"moreresources" : [
]
}]
